Certain compounds of formula (I) below or a pharmaceutically acceptable salt or hydrate thereof: a process for preparing such compounds, a pharmaceutical composition comprising such compounds and the use of such compounds and composition in medicine.
A DIOXINO[2,3-G]QUINOLINE-9-CARBOXYLIC ACID DERIVATIVE AS NK3 RECEPTOR ANTAGONIST
申请人:GlaxoSmithKline S.p.A.
公开号:EP1377555B1
公开(公告)日:2007-01-24
[EN] QUINOLINE DERIVATIVES AS NK-3 ANTAGONISTS<br/>[FR] DERIVES DE QUINOLINE UTILISES COMME ANTAGONISTES DE NK-3
申请人:GLAXOSMITHKLINE SPA
公开号:WO2002044165A1
公开(公告)日:2002-06-06
Certain compounds of formula (I) below or a pharmaceutically acceptable salt or hydrate thereof: a process for preparing such compounds, a pharmaceutical composition comprising such compounds and the use of such compounds and composition in medicine.